ValeantPharmaceuticals posts

Feed

Options Update: Target Volatility Flat; Shares Near 8-Month Low

Target (TGT) overall option implied volatility of 24 is near its 26-week average, according to Track Data, suggesting non-directional term price movement.

Valeant Pharmaceuticals (VRX) announced it made a proposal to the Board of Directors of Cephalon (CEPH), to acquire Cephalon for $73.00 per share in cash. Cephalon overall option implied volatility of 25 is below its 26-week average of 30, according to Track Data, suggesting decreasing price movement.

Update is by Stock Specialist Paul Foster of theflyonthewall.com

Three Small Cap Buyout Targets

A 21-month run of rock-bottom interest rates have created a perfect environment for corporate bonds --- and as bond yields fall, bond prices rise and investors and companies have made out like bandits. This has put so much cash in corporate coffers that cash (as a percentage of S&P 500 market capitalization and excluding financials) has soared from just 3% of market value back in 1999 to more than 12.5% today! This cash is burning a hole in the pockets of many companies, and they are starting to use it to make bids for other companies so they can grab market share and expand on the cheap.

That's great news for small cap stocks with strong fundamentals, since these are always prime buyout targets. And here are three:

Continue reading Three Small Cap Buyout Targets

Valeant Pharma (VRX) falls on bearish Barron's coverage

VRX logoValeant Pharmaceuticals (VRX - option chain) stock is trading lower today after an article in Barron's (subscription required) over the weekend said the company could see trouble ahead if its experimental epilepsy drug, which is undergoing the regulatory review process, is not profitable enough to offset declining royalties from its hepatitis C treatment. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on VRX.

This morning, VRX opened at $32.15. So far today the stock has hit a high of $32.95 and a low of $31.88. As of 11:30, VRX is trading at $32.07, down $1.21 (-3.6%). The chart for VRX looks bullish.

Continue reading Valeant Pharma (VRX) falls on bearish Barron's coverage

Symbol Lookup
IndexesChangePrice
DJIA-74.9212,454.83
NASDAQ-1.852,837.53
S&P 500-2.861,317.82

Last updated: May 27, 2012: 09:09 PM

Hot Stocks

General Electric

19.20-0.05(-0.26)

Alcoa

8.630.00(0.00)

Apple Inc

562.29-3.03(-0.54)

Google Inc 'A'

591.53-12.13(-2.01)

Bank of America

7.15+0.01(+0.14)

Wal-Mart Stores

65.31+0.24(+0.37)

Exxon Mobil Corp

82.08-0.53(-0.64)

Ford

10.60+0.01(+0.09)

Citigroup

26.47-0.19(-0.71)

IBM

194.30-1.79(-0.91)

Yahoo

15.36+0.01(+0.07)

Starbucks

54.56-0.20(-0.37)

Microsoft

29.06-0.01(-0.03)

Home Depot

49.44-0.27(-0.54)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1338167360996 ms.